Immunovaccine Technologies begins enrollment in phase I trial of DPX-0907 cancer vaccine March 31, 2010
Favorable preclinical safety of bispecific MM-111 antibody for HER2-positive solid tumors disclosed March 31, 2010
EMA approves combination of Xeloda and oxaliplatin for adjuvant treatment of early colon cancer March 30, 2010
MannKind achieves milestones in collaboration with Multiple Myeloma Research Foundation March 30, 2010
Primera Bioscience Research's project with the Hospital for Sick Children achieves major milestone March 30, 2010
RSS